|
Market Cap (22-May) $2,155,156,224 (333rd) |
Close (30-Jun) $1.14 |
Volume (30-Jun) 2,606,681 |
Shortsold (5-May) 72,824,861 (5.70%) (40th) |
|
52w High $3.37 |
52w Low $0.88 |
P/E 454.55 |
EPS -0.14 |
MSB released this announcement to the ASX on 16 July 2021, 9:39. The announcement is not marked as price sensitive, and is 27 page(s) in length and 2.87MB in size.
You can view all announcements from MSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, MSB was 6.686% short sold according to ASIC data. It was ranked the 10th most shorted stock on the ASX. It remains ranked 40th as of the latest reported data (05 May 2025).
| Other Recent Announcements from MSB | |
|---|---|
| Change of Director's Interest Notice | 13 June 2023, 8:56 |
| Mesoblast Director Appointed to Strategic Advisory Role | 5 June 2023, 9:41 |
| MSB Reports Q3 Financial Results and Operational Highlights | 26 May 2023, 8:32 |
| COVID ARDS Trial Results Presentation | 16 July 2021, 9:39 |
| Appendix 3Y - Change of Director's Interest Notice | 14 July 2021, 17:55 |
| Appendix 3G | 7 July 2021, 17:50 |
| Mesoblast Update on Chronic Low Back Pain Program | 1 July 2021, 9:00 |
You must be logged in to post a reply.
Mesoblast 